Alora Pharmaceuticals

Alora Pharmaceuticals

Alora Pharmaceuticals is structured as a parent company for a family of specialty pharmaceutical businesses, based in Alpharetta, Georgia. The firm does not disclose its founding year or ownership structure publicly; its website emphasizes an entrepreneurial approach to acquiring or developing drug assets across multiple therapeutic areas. The company operates through several subsidiaries that target distinct market segments. Vertical Pharmaceuticals markets branded products in women's health, hematology, and dermatology. Acella Pharmaceuticals focuses on desiccated thyroid extract and other endocrine treatments. A generic division supplies dietary supplements, drugs, and medical solutions. A novel-products unit develops therapies for women's health, pain management, and ADHD. Alora also runs a contract development and manufacturing organization (CDMO) specializing in controlled and modified drug delivery systems. Geographic reach is primarily US-focused, with no disclosed international offices. Alora does not publicly report AUM, number of employees, or total deployment. The firm's LinkedIn presence was not captured. In a recent operational update, Vertical Pharmaceuticals partnered with Medfinder to help patients locate Relexxii® amid ongoing ADHD medication shortages (per company website, 2024). Acella Pharmaceuticals publicly thanked the FDA for maintaining access to desiccated thyroid extract products (per company website, 2024). The structural differentiator of Alora Pharmaceuticals is its holding-company model: rather than operating as a single integrated pharma firm, it owns a collection of quasi-independent subsidiaries with separate brand identities, regulatory histories, and go-to-market strategies. This allows the parent to platform specialized capabilities—such as controlled-release CDMO expertise—while letting each subsidiary maintain its own therapeutic focus and regulatory relationships. Ownership and governance details remain undisclosed.